Latest news
FDA Approves RP1 Plus Nivolumab for Advanced Melanoma - Dermatology TimesDermatology Times · Fri, 07 Aug 2026 19:11:16 GMTThree-Phase Topical Isotretinoin Strategy Extends Acne Care Beyond Active Breakouts - Dermatology TimesDermatology Times · Fri, 07 Aug 2026 17:09:44 GMTIt’s Official: US FDA Approves Replimune’s Melanoma Drug - The Dermatology DigestThe Dermatology Digest · Thu, 06 Aug 2026 21:37:13 GMTBrooke Shields: From Hollywood Icon to Powerful Skin Health Advocate - OncodailyOncodaily · Wed, 05 Aug 2026 22:16:11 GMTConexeu Sciences Advances Bio-Regenerative ECM Platform for Structural Tissue Restoration - Dermatology TimesDermatology Times · Tue, 04 Aug 2026 18:08:28 GMTGenetic Complexity Behind EB Simplex Slows Gene Therapy Progress - Dermatology TimesDermatology Times · Wed, 29 Jul 2026 07:00:00 GMT